GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $81,000 | +3.8% | 1,861 | +4.0% | 0.01% | 0.0% |
| Q1 2022 | $78,000 | -1.3% | 1,789 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $79,000 | +16.2% | 1,789 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $68,000 | -43.8% | 1,789 | -41.0% | 0.01% | -50.0% |
| Q2 2021 | $121,000 | +12.0% | 3,031 | 0.0% | 0.02% | -56.5% |
| Q1 2021 | $108,000 | -3.6% | 3,031 | 0.0% | 0.05% | -8.0% |
| Q4 2020 | $112,000 | -77.6% | 3,031 | -77.2% | 0.05% | -74.7% |
| Q3 2020 | $500,000 | -10.6% | 13,294 | -3.0% | 0.20% | -17.2% |
| Q2 2020 | $559,000 | +10.9% | 13,704 | +3.1% | 0.24% | -4.0% |
| Q1 2020 | $504,000 | -20.9% | 13,294 | -1.9% | 0.25% | +0.8% |
| Q4 2019 | $637,000 | +10.8% | 13,546 | +0.5% | 0.25% | -3.1% |
| Q3 2019 | $575,000 | +6.7% | 13,477 | 0.0% | 0.26% | +4.9% |
| Q2 2019 | $539,000 | -22.8% | 13,477 | -19.3% | 0.24% | -20.8% |
| Q1 2019 | $698,000 | +9.4% | 16,706 | 0.0% | 0.31% | -0.6% |
| Q4 2018 | $638,000 | -5.1% | 16,706 | -0.2% | 0.31% | +10.0% |
| Q3 2018 | $672,000 | -0.9% | 16,735 | -0.5% | 0.28% | -6.6% |
| Q2 2018 | $678,000 | +3.8% | 16,821 | +0.7% | 0.30% | -0.3% |
| Q1 2018 | $653,000 | +9.0% | 16,706 | -1.1% | 0.30% | +14.8% |
| Q4 2017 | $599,000 | -17.6% | 16,889 | -5.6% | 0.26% | -26.1% |
| Q3 2017 | $727,000 | -5.8% | 17,900 | 0.0% | 0.36% | -9.6% |
| Q2 2017 | $772,000 | -4.3% | 17,900 | -6.4% | 0.39% | -6.4% |
| Q1 2017 | $807,000 | +9.5% | 19,130 | 0.0% | 0.42% | +9.1% |
| Q4 2016 | $737,000 | -11.3% | 19,130 | -0.8% | 0.39% | -14.6% |
| Q3 2016 | $831,000 | -5.9% | 19,275 | -5.4% | 0.45% | -7.8% |
| Q2 2016 | $883,000 | -6.2% | 20,372 | -12.3% | 0.49% | -6.1% |
| Q1 2016 | $941,000 | -1.3% | 23,218 | -1.7% | 0.52% | -1.7% |
| Q4 2015 | $953,000 | +3.9% | 23,610 | -1.0% | 0.53% | -4.0% |
| Q3 2015 | $917,000 | -7.7% | 23,856 | 0.0% | 0.55% | -2.8% |
| Q2 2015 | $994,000 | -9.9% | 23,856 | -0.2% | 0.57% | -17.8% |
| Q1 2015 | $1,103,000 | +4.8% | 23,896 | -2.9% | 0.69% | +6.3% |
| Q4 2014 | $1,052,000 | -8.1% | 24,616 | -1.2% | 0.65% | -9.8% |
| Q3 2014 | $1,145,000 | -14.0% | 24,904 | 0.0% | 0.72% | -10.0% |
| Q2 2014 | $1,332,000 | +0.1% | 24,904 | 0.0% | 0.80% | -7.6% |
| Q1 2014 | $1,331,000 | -4.9% | 24,904 | -5.0% | 0.87% | -1.1% |
| Q4 2013 | $1,399,000 | +11.1% | 26,207 | +4.4% | 0.88% | -8.3% |
| Q3 2013 | $1,259,000 | +0.4% | 25,104 | 0.0% | 0.96% | +0.5% |
| Q2 2013 | $1,254,000 | +5352.2% | 25,104 | +4920.8% | 0.95% | +3708.0% |
| Q1 2013 | $23,000 | – | 500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |